ArticleCancers2020

Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2.

Verena Barbarino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.